Our findings are in accordance with the study published by Quinn et al. (Quinn et al., 2017) reporting that letrozole use was associated with a decreased maturity rate compared to the standard GnRH antagonist protocol in breast cancer patients and compared to those undergoing fertility preservation. Here, GNRH1 is linked to breast carcinoma.